Puma Biotechnology IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 7.98 USD | 8,75 USD | 3,03 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5 USD | 0 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 50.899.456 | 9,02 | 10,02 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Puma Biotechnology Inc
Mitarbeiter 179
Handelsplatz NASDAQ
Ticker Symbol PBYI
IPO Datum 2012-04-24
Adresse 10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
Webseite https://www.pumabiotechnology.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Alan H. Auerbach | Founder, Chairman, President, CEO & Secretary |
| 2 | Mr. Maximo F. Nougues | CFO & Principal Accounting Officer |
| 3 | Mr. Douglas Hunt B.Sc., FRAPS | Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer |
| 4 | Mr. Gordon G. Esplin | Chief Accounting Officer |
| 5 | Mr. Mariann Ohanesian | Senior Director of Investor Relations |
| 6 | Ms. Heather Blaber | Senior Vice President of Marketing |
| 7 | Mr. Roger L. Storms | Senior Vice President of Sales |
| 8 | Ms. Pamela Wilson BA | Senior Vice President of Clinical Operations |
| 9 | Dr. Petra Rietschel | Senior Vice President of Clinical Development |
| 10 | Mr. Kenneth Wiehe | Senior Vice President of Supply Chain & Manufacturing |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 4 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 5 | American Century Companies Inc | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 9 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | LSV Asset Management | 0,00% | 0,00 Mio. USD |
| 11 | O'Shaughnessy Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 12 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 14 | Kennedy Capital Management Inc | 0,00% | 0,00 Mio. USD |
| 15 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Connor Clark & Lunn Inv Mgmt Ltd | 0,00% | 0,00 Mio. USD |
| 17 | Bridgeway Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Comprehensive Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 20 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |